Age at HTx, mean ± SD, years | |
Recipient (R) | 45 ± 13 |
Donor (D) | 33 ± 12 |
Male gender, n (%) | |
Recipient | 176 (78) |
Donor | 159 (70) |
Body mass index at HTx, mean ± SD kg/m2 | 23.8 ± 3.9 |
Cold ischemic time, mean ± SD minutes CMV serology, n (%) | 168 ± 49 |
D+ /R− | 46 (20) |
D+ /R+ | 101 (45) |
D− /R+ | 64 (28) |
D− /R− | 15 (7) |
Induction therapy, n (%) | |
CsA | 48 (21) |
ATG | 165 (73) |
Daclizumab | 4 (2) |
Prednisone | 9 (4) |
CAD, n (%) | 73 (32) |
Hypertension, n (%) | 30 (13) |
Diabetes Mellitus, n (%) | 23 (10) |
Previous smoking, n (%) | 127 (56) |
TRS at 1 year, mean ± SD | 0.49 ± 0.30 |
TRS ≥ 2R at 1 year, mean ± SD | 0.22 ± 0.20 |